Skip to main content

CTAD: Anti-tau vaccine demonstrated safety, immunogenicity in phase I study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
CTAD: Anti-tau vaccine demonstrated safety, immunogenicity in phase I study

User login

Username

Password

Reset your password

Type	Lead	score